{
    "clinical_study": {
        "@rank": "30041", 
        "arm_group": {
            "arm_group_label": "rabies vaccine", 
            "arm_group_type": "Experimental", 
            "description": "When injured by the animal who carries the rabies virus, the patient after standard treatment would survive or die"
        }, 
        "brief_summary": {
            "textblock": "The objective of this study was to achieve the post-marketing protective effect research of\n      Speeda\u00ae rabies vaccine for human use from Chengda Bio."
        }, 
        "brief_title": "The Protection Effect of Speeda\u00ae Rabies Vaccine for Human Use", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Rabies Vaccine Allergy", 
        "condition_browse": {
            "mesh_term": "Rabies"
        }, 
        "detailed_description": {
            "textblock": "When found the injury who is bitten by the animal to three-level, the investigators would\n      enroll the participant after explaining the protection and making him signed the informed\n      consent. The patient would inject rabies vaccine as follow the national regulation,\n      meanwhile the investigators would get the blood samples to detect whether the man-killer\n      carries the rabies virus."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Parent/legal acceptable representatives of children or the adult participants are\n             willing and able to understand the protocol requirements and provide informed consent\n             signed\n\n          -  Participant is considered to be in good health including the body and mental status\n             on the basis of reported medical history and limited physical examination and live in\n             local \u2265 12 months before injured\n\n          -  The man-killer could found and detect whether it carries the virus\n\n        Exclusion Criteria:\n\n          -  Known bleeding disorder or suspected impairment of immunologic function, or receipt\n             of immunosuppressive therapy or immunoglobulin since birth\n\n          -  Apply passive immunity preparation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01827917", 
            "org_study_id": "BJCDPC-6"
        }, 
        "intervention": {
            "arm_group_label": "rabies vaccine", 
            "description": "Injection on day 0\u30017\u300121", 
            "intervention_name": "rabies vaccine", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 11, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Changsha", 
                    "country": "China", 
                    "state": "Hunan"
                }, 
                "name": "Hunan Centers for Disease Control and Prevention"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "1", 
        "official_title": "Phase 4 Study of Speeda\u00ae Rabies Vaccinia That Use for Protection the Crowd Bitten by Animals to Three-level", 
        "overall_official": {
            "affiliation": "Beijing Chaoyang District Centers for Disease Control and Prevention", 
            "last_name": "Nianmin Shi", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Whether or when would the patients develop symptoms after injured by the animals carrying the virus", 
            "measure": "Observation of the subject after injured by the animals carrying the virus", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01827917"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Beijing Center for Disease Control and Prevention", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Beijing Center for Disease Control and Prevention", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}